chrX-70035434-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM1PM2PP3
The ENST00000374552.9(EDA):c.1001G>C(p.Arg334Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R334H) has been classified as Benign.
Frequency
Consequence
ENST00000374552.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EDA | NM_001399.5 | c.1001G>C | p.Arg334Pro | missense_variant | 8/8 | ENST00000374552.9 | NP_001390.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EDA | ENST00000374552.9 | c.1001G>C | p.Arg334Pro | missense_variant | 8/8 | 1 | NM_001399.5 | ENSP00000363680 | P4 | |
EDA | ENST00000374553.6 | c.995G>C | p.Arg332Pro | missense_variant | 8/8 | 1 | ENSP00000363681 | A1 | ||
EDA | ENST00000524573.5 | c.986G>C | p.Arg329Pro | missense_variant | 8/8 | 1 | ENSP00000432585 | A1 | ||
EDA | ENST00000616899.1 | c.605G>C | p.Arg202Pro | missense_variant | 7/7 | 5 | ENSP00000481963 |
Frequencies
GnomAD3 genomes Cov.: 21
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 21
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 17, 2015 | Variant classified as Uncertain Significance - Favor Pathogenic. The p.Arg334Pro variant in EDA has been identified by our laboratory in 1 male with XLHED and 2 mildly affected females in the same family. It was absent from large population studies. Another change at this position (p.Arg334His) has been reported in one Asian individual with non-syndromic oligodontia and his clinically unaffected m other (consistent with skewed X-inactivation patterns and subclinical phenotypes in females) (Song 2009), but the p.Arg334His variant was also present in 0.9% ( 66/5927, including 9 males) of East Asian chromosomes by the Exome Aggregation C onsortium (ExAC, http://exac.broadinstitute.org, dbSNP rs142948132). While this high frequency in the general population suggests a less likely pathogenic role, the clinical description of individuals included in this database is not provid ed. Thus, it is possible that some of these individuals manifest some features o f HED and that the p.Arg334His variant represents a common pathogenic variant in the East Asian population. Computational prediction tools and conservation anal ysis do not provide strong support for or against an impact of the p.Arg334Pro v ariant to the protein. In summary, while there is some suspicion for a pathogeni c role due to its segregation in affected family members, the clinical significa nce of the p.Arg334Pro variant is uncertain. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at